The move intensifies an ongoing legal battle, as Novo Nordisk joins its major competitor Eli Lilly in opposing a recent initiative by the Outsourcing Facilities Association to include liraglutide in ...
Our vision is to innovate and incorporate promising technologies to communicate freely available, high-priority, high-quality content, which accelerates scientific progress and advances heart and ...
The FDA finalized Monday an interim regulatory policy for outsourcing facilities that compound drugs using bulk drug substances while the agency develops a list of medicines that have a clinical need.